Expression of Protein Kinase C α and the MZF-1 and Elk-1 Transcription Factors in Human Breast Cancer Cells

10.4077/CJP.2012.AMM109

Chia-Herng Yue；Yung-Wei Chiu；Jai-Nien Tung；Bor-Show Tzang；Jiuan-Jen Shiu；Wen-Hung Huang；Jer-Yuh Liu；Jin-Ming Hwang

PKCα ； Elk-1 ； MZF-1 ； Human breast cancer cells

The Chinese Journal of Physiology

55卷1期（2012 / 02 / 01）

31 - 36

英文

Recently, our research into hepatocellular carcinoma (HCC) has shown that the transcription factors Myeloid Zinc Finger-1 (MZF-1) and Ets-like-protein 1 are related to protein kinase C alpha (PKCα) expression. The purpose of this study was to determine the correlation of the expression of PKCα with the expressions of Elk-1 and MZF-1 in various differentiated breast cancer cell lines: MDAMB-231, Hs57BT, SKBR3, MDA-MB-468 and MCF-7. The malignant potential in the five lines of breast cancer cells was examined by using a cell proliferation/migration/invasion assay and the protein and mRNA levels of PKCα, ElK-1 and MZF-1 were examined by Western blot and RT-PCR analysis, respectively. The results showed that there were obvious signs of migration and invasion of cells in MDAMB-231 and Hs57BT cells, little signs of cell migration and invasion in MDA-MB-468 cells, and no sign in SKBR3 and MCF-7 cells. Moreover, the highest expression levels of PKCα, Elk-1 and MZF-1 were also observed in MDA-MB-231 and Hs57BT cells when compared to the other breast cancer cell lines. These findings confirm that elevated expression of PKCα in breast cancer cells may be correlated with the potential of cell migration and invasion, and suggest an association between the expression of PKCα and the expression of the transcription factors Elk-1 and MZF-1.

1. Hsieh, Y.H.,Wu, T.T.,Huang, C.Y.,Hsieh, Y.S.,Liu, J.Y.(2007).Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1.Chinese J. Physiol.,50,9-15.
   連結：
2. Tsai, J.H.,Tsai, M.T.,Su, W.W.,Chen, Y.L.,Wu, T.T.,Hsieh, Y.S.,Huang, C.Y.,Yeh, K.T.,Liu, J.Y.(2005).Expression of protein kinase C α in biopsies, surgical specimens of human hepatocellular carcinoma.Chinese J. Physiol.,48,139.
   連結：
3. Ahmad, S.,Glazer, R.I.(1993).Expression of the antisense cDNA for protein kinase C α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol.,43,858-862.
4. Ainsworth, P.D.,Winstanley, J.H.R.,Pearson, J.M.,Bishop, H.M.,Garrod, D.R.(2004).Protein kinase C α expression in normal breast, ductal carcinoma in situ, invasive ductal carcinoma.Eur. J. Cancer,40,2269-2273.
5. ALi, S.,Al-Sukhun, S.,El-Rayes, B.,Sarkar, F.,Heilbrun, L.,Philip, P.(2009).Protein kinases C isozymes are differentially expressed in human breast carcinomas.Life Sci.,84,766-771.
6. Assender, J.W.,Gee, J.M.W.,Lewis, I.,Ellis, I.O.,Robertson, J.F.R.,Nicholson, R.I.(2007).Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.J. Clin. Pathol.,60,1216-1221.
7. Blasi, F.(1999).Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system.Thromb. Haemost.,82,298-304.
8. De Petro, G.,Tavian, D.,Copeta, A.,Portolani, N.,Giulini, S.M.,Barlati, S.(1998).Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.Cancer Res.,58,2234-2239.
9. Fournier, D.B.,Chisamore, M.,Lurain, J.R.,Rademaker, A.W.,Jordan, V.C.,Tonetti, D.A.(2001).Protein kinase C α expression is inversely related to ER status in endometrial carcinoma: possible role in possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.Gynecol. Oncol.,81,366-372.
10. Gordge, P.C.,Hulme, M.J.,Clegg, R.A.,Miller, W.R.(1996).Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue.Eur. J. Cancer,32,2120-2126.
11. Hsieh, Y.H.,Wu, T.T.,Huang, C.Y.,Hsieh, Y.S.,Hwang, J.M.,Liu, J.Y.(2007).p38 Mitogen-activated protein kinase pathway is involved in protein kinase Cα-regulated invasion in human hepatocellular carcinoma cells.Cancer Res.,67,4320-4327.
12. Hsieh, Y.H.,Wu, T.T.,Tsai, J.H.,Huang, C.Y.,Hsieh, Y.S.,Liu, J.Y.(2006).PKCα expression regulated by Elk-1, MZF-1 in human HCC cells.Biochem. Biophys. Res. Commun.,339,217-225.
13. Jiang, X.H.,Tu, S.P.,Cui, J.T.,Lin, M.C.M.,Xia,H.H.X.,Wong, W.M.,Chan, A.O.O.,Yuen, M.F.,Jiang, S.H.,Lam, S.K.,Kung, H.F.,Soh, J.W.,Weinstein, I.B.,Wong, B.C.Y.(2004).Antisense targeting protein kinase C α, β 1 inhibits gastric carcinogenesis.Cancer Res.,64,5787-5794.
14. Kerfoot, C.,Huang, W.,Rotenberg, S.A.(2004).Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C α..J. Histochem. Cytochem.,52,419-422.
15. Koivunen, J.,Aaltonen, V.,Koskela, S.,Lehenkari, P.,Laato, M.,Peltonen, J.(2004).Protein kinase Cα/β inhibitor Go6976 promotes formation of cell junctions, inhibits invasion of urinary bladder carcinoma cells.Cancer Res.,64,5693-5701.
16. Koren, R.,Ben, M.D.,Langzam, L.,Dekel, Y.,Konichezky, M.,Baniel, J.,Livne, P.M.,Gal, R.,Sampson, S.R.(2004).Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.Oncol. Rep.,11,321-326.
17. Lahn, M.,Kohler, G.,Sundell, K.,Su, C.,Li, S.,Paterson, B.M.,Bumol, T.F.(2004).Protein kinase C α expression in breast and ovarian cancer.Oncology,67,1-10.
18. Langzam, L.,Koren, R.,Gal, R.,Kugel, V.,Paz, A.,Farkas, A.,Sampson, S.R.(2001).Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder.Am. J. Clin. Pathol.,116,377-385.
19. Lindemann, R.K.,Braig, M.,Ballschmieter, P.,Guise, T.A.,Nordheim, A.,Dittmer, J.(2003).Protein kinase Cα regulates Ets1 transcriptional activity in invasive breast cancer cells.Int. J. Oncol.,22,799-805.
20. Liu, B.,Maher, R.J.,Hannun, Y.A.,Porter, A.T.,Honn, K.V.(1994).12 (S)-HETE enhancement of prostate tumor cell invasion: selective role of PKCα..J. Natl. Cancer Inst,86,1145-1151.
21. Lonne, G.,Cornmark, L.,Zahirovic, I.,Landberg, G.,Jirstrom, K.,Larsson, C.(2010).PKCα expression is a marker for breast cancer aggressiveness.Mol. Cancer,9,76.
22. Magnifico, A.,Albano, L.,Campaner, S.,Campiglio, M.,Pilotti, S.,Menard, S.,Tagliabue, E.(2007).Protein kinase Cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification.Cancer Res.,67,5308-5317.
23. Mandil, R.,Ashkenazi, E.,Blass, M.,Kronfeld, I.,Kazimirsky, G.,Rosenthal, G.,Umansky, F.,Lorenzo, P.S.,Blumberg, P.M.,Brodie, C.(2001).Protein kinase Cα, protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells.Cancer Res.,61,4612-4619.
24. Mao, M.,Fang, X.,Lu, Y.,Lapushin, R.,Bast, R.C., Jr.,Mills, G. B.(2000).Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.Biochem. J.,352,475-482.
25. Morse-Gaudio, M.,Connolly, J.M.,Rose, D.P.(1998).Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype.Int. J. Oncol.,12,1349-1354.
26. Nakashima, S.(2002).Protein kinase Cα (PKCα): regulation and biological function.J. Biochem.,132,669-675.
27. Newton, A.C.(1995).Protein kinase C: structure, function and regulation.J. Biol. Chem.,270,28495-28498.
28. Ng, T.,Squire, A.,Hansra, G.,Bornancin, F.,Prevostel, C.,Hanby, A.,Harris, W.,Barnes, D.,Schmidt, S.,Mellor, H.(1999).Imaging protein kinase Cα activation in cells.Science,283,2085-2089.
29. O''Brian, C.A.,Vogel, V.G.,Eva Singletary, S.,Ward, N.E.(1989).Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue.Cancer Res.,49,3215-3217.
30. Ohno, S.,Nishizuka, Y.(2002).Protein kinase C isotypes and their specific functions: prologue.J. Biochem.,132,509-511.
31. Sliva, D.,English, D.,Lyons, D.,Lloyd, F.P.(2002).Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-κB.Biochem. Biophys. Res. Commun.,290,552-557.
32. Sun, X.G.,Rotenberg, S.A.(1999).Overexpression of protein kinase Cα in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility.Cell Growth Differ,10,343-352.
33. Varga, A.,Czifra, G.,TalLai, B.,Nemeth, T.,Kovacs, I.,Kovacs, L.,Biro, T.(2004).Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas.Eur. Urol.,46,462-465.
34. Wang, X.Y.,Repasky, E.,Liu, H.T.(1999).Antisense inhibition of protein kinase Cα reverses the transformed phenotype in human lung carcinoma cells.Exp. Cell Res.,250,253-263.
35. Ways, D.K.,Kukoly, C.A.,deVente, J.,Hooker, J.L.,Bryant, W.O.,Posekany, K.J.,Fletcher, D.J.,Cook, P.P.,Parker, P.J.(1995).MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.J. Clin. Invest.,95,1906-1915.
36. Wu, T.T.,Hsieh, Y.H.,Hsieh, Y.S.,Liu, J.Y.(2008).Reduction of PKCα decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.J. Cell. Biochem.,103,9-20.
37. Ying, T.H.,Hsieh, Y.H.,Hsieh, Y.S.,Liu, J.Y.(2008).Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.Cell Biol. Int.,32,210-216.
38. Zhang, Y.,Zhao, H.,Asztalos, S.,Chisamore, M.,Sitabkhan, Y.,Tonetti, D.(2009).Estradiol-induced regression in T47D: A18/PKCα tumors requires the estrogen receptor and interaction with the extracellular matrix.Mol. Cancer Res.,7,498-510.

1. Zhang, Jie,Zhang, Jiao,Yu, Chao,Yao, Sihong,Yang, Xiaomeng,Tang, Peizhi,Tan, Dunyong,Nie, Xi,Mamat, Zulbnur,Li, Zhongzheng,Jiang, Huang,Huang, Jianjun(2015).Histone 3 Trimethylation of IGFBP-7 Gene Promoter by Expression of D5 Stat5a in Breast Epithelial Cells.中國生理學雜誌,58(5),275-284.